SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE535.60-4.75 (-0.88 %)
PREV CLOSE ( ) 540.35
OPEN PRICE ( ) 541.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 62070
TODAY'S LOW / HIGH ( )532.00 543.65
52 WK LOW / HIGH ( )433.15 758.5
NSE535.75-4.45 (-0.82 %)
PREV CLOSE( ) 540.20
OPEN PRICE ( ) 540.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 434929
TODAY'S LOW / HIGH( ) 532.00 543.00
52 WK LOW / HIGH ( )432.7 759
Select year
Particulars
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Operational & Financial Ratios
 
 
 
 
 
   Earnings Per Share (Rs)
29.03  
18.89  
21.92  
15.17  
28.87  
   CEPS(Rs)
37.93  
27.82  
32.27  
20.70  
18.40  
   DPS(Rs)
3.50  
1.00  
3.00  
1.50  
5.00  
   Book NAV/Share(Rs)
152.70  
137.03  
123.49  
89.44  
144.74  
   Tax Rate(%)
13.39  
13.91  
14.29  
15.33  
19.57  
Margin Ratios
 
 
 
 
 
   Core EBITDA Margin(%)
30.66  
28.64  
28.11  
42.76  
42.39  
   EBIT Margin(%)
29.92  
24.90  
25.24  
28.42  
38.05  
   Pre Tax Margin(%)
28.65  
23.07  
23.14  
28.15  
37.68  
   PAT Margin (%)
24.82  
19.86  
19.84  
23.83  
30.30  
   Cash Profit Margin (%)
28.82  
23.50  
24.16  
26.35  
33.24  
Performance Ratios
 
 
 
 
 
   ROA(%)
14.08  
11.39  
14.60  
16.21  
19.61  
   ROE(%)
22.51  
19.32  
24.89  
23.15  
25.53  
   ROCE(%)
21.48  
18.64  
25.06  
25.46  
31.39  
   Asset Turnover(x)
0.57  
0.57  
0.74  
0.68  
0.65  
   Sales/Fixed Asset(x)
1.35  
1.34  
1.79  
1.70  
1.51  
   Working Capital/Sales(x)
2.10  
1.70  
2.17  
1.28  
1.32  
Efficiency Ratios
 
 
 
 
 
   Fixed Capital/Sales(x)
0.74  
0.75  
0.56  
0.59  
0.66  
   Receivable days
80.78  
76.12  
48.20  
51.72  
71.46  
   Inventory Days
76.61  
77.46  
57.99  
63.92  
74.22  
   Payable days
75.92  
75.24  
52.05  
56.33  
65.15  
Valuation Parameters
 
 
 
 
 
   PER(x)
23.69  
43.38  
46.64  
37.80  
14.17  
   PCE(x)
18.13  
29.46  
31.68  
27.69  
22.23  
   Price/Book(x)
4.50  
5.98  
8.28  
6.41  
5.65  
   Yield(%)
0.51  
0.12  
0.29  
0.26  
0.61  
   EV/Net Sales(x)
5.10  
6.85  
7.66  
7.07  
7.16  
   EV/Core EBITDA(x)
14.91  
21.84  
24.92  
15.06  
15.32  
   EV/EBIT(x)
16.90  
27.14  
30.04  
24.59  
18.55  
   EV/CE(x)
2.71  
3.68  
4.46  
4.03  
4.12  
   M Cap / Sales
5.27  
7.02  
7.73  
7.38  
7.50  
Growth Ratio
 
 
 
 
 
   Net Sales Growth(%)
11.38  
2.62  
70.34  
42.31  
40.90  
   Core EBITDA Growth(%)
21.50  
4.78  
11.42  
42.91  
43.76  
   EBIT Growth(%)
33.18  
1.60  
50.95  
5.97  
28.95  
   PAT Growth(%)
38.53  
3.07  
41.49  
11.60  
14.21  
   EPS Growth(%)
53.67  
-13.82  
44.50  
-47.46  
12.48  
Financial Stability Ratios
 
 
 
 
 
   Total Debt/Equity(x)
0.27  
0.26  
0.35  
0.14  
0.02  
   Current Ratio(x)
1.84  
2.28  
1.79  
3.12  
4.05  
   Quick Ratio(x)
1.46  
1.79  
1.44  
2.60  
3.14  
   Interest Cover(x)
23.63  
13.56  
12.06  
104.67  
101.13  
   Total Debt/Mcap(x)
0.06  
0.04  
0.04  
0.02  
0.01  
ATTENTION INVESTORSKYC
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.